Enterprise Value

3.634B

Cash

402.9M

Avg Qtr Burn

-13.91M

Short % of Float

8.23%

Insider Ownership

0.23%

Institutional Own.

97.71%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

sNDA

FDA meeting

Phase 3

Data readout

ACP-204 Details
Alzheimer's disease

Phase 1

Update

ACP-044 Details
Pain, Post operative acute pain

Failed

Discontinued